Body mass index change in autism spectrum disorders: comparison of treatment with risperidone and aripiprazole.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The purpose of this study was to assess change in body mass index (BMI) and age- and gender-adjusted BMI Z-score in subjects ages 2-20 years with autism spectrum disorders (ASD), who were treated longitudinally with risperidone or aripiprazole at a tertiary care ASD clinic.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Child Adolesc Psychopharmacol

Title: Journal of child and adolescent psychopharmacology

ISSN (Electronic): 1557-8992

ISSN (Print): 1044-5463

Publication date (Electronic): Mar 2014

Volume: 24

Issue: 2

Affiliations

[1 ] 1 Cincinnati Children's Hospital Medical Center , Cincinnati, Ohio.

Article

DOI: 10.1089/cap.2013.0099

PubMed ID: 24564519

Data availability:

Comments

Comment on this article

Cited by 11

See all cited by